News Archive - Lexaria Energy

Lexaria Files New Patent Application

Vancouver, British Columbia – June 22, 2017 – Lexaria Bioscience Corp. (OTCQB:LXRP) (CSE:LXX) (the “Company” or “Lexaria”) announces the filing of a new provisional patent application and stock and option…

Lexaria Appoints New Acting CFO

Vancouver, British Columbia – June 5, 2017 – Lexaria Bioscience Corp. (OTCQB:LXRP) (CSE:LXX) (the “Company” or “Lexaria”) is pleased to announce that its has appointed Allan Spissinger as new acting…

Lexaria raises US$1M from Warrant Exercise

Kelowna, BC / May 19, 2017 / Lexaria Bioscience Corp (OTCQB:LXRP) (CSE:LXX) (the "Company" or "Lexaria") announces it has received US$970,230.05 from the exercise of warrants previously granted. The stock…

Lexaria Featured on Television

Kelowna, BC / May 18, 2017 / Lexaria Bioscience Corp. (OTCQB:LXRP) (CSE:LXX) (the "Company" or "Lexaria") is one of five companies featured on a special BTV episode exploring burgeoning cannabis…

Lexaria Announces Research on Nonsteroidal Anti-Inflammatory Drugs

Kelowna, BC / May 10, 2017 / Lexaria Bioscience Corp (OTCQB:LXRP) (CSE:LXX) (the “Company”, “Lexaria”) announces plans for research and formulation development (“R&D”) on nonsteroidal anti-inflammatory drugs (“NSAIDs”) utilizing its…

Lexaria Announces R&D on Nicotine

Kelowna, BC / May 4, 2017 / Lexaria Bioscience Corp (OTCQB:LXRP) (CSE:LXX) (the “Company”, “Lexaria”) is announcing new plans to commence nicotine absorption research beginning in the summer of 2017,…